CHLAMYDIA TRACHOMATISVIRCLIA® IGA/IGG/IGM MONOTEST
CHLAMYDIA TRACHOMATIS VIRCLIA®IGA/IGG/IGM MONOTEST ES UNINMUNOENSAYO QUIMIOLUMINISCENTEINDIRECTO (CLIA) PARA DETERMINARANTICUERPOS IGA, IGG E IGM ESPECÍFICOSFRENTE A CHLAMYDIA TRACHOMATIS ENSUERO/PLASMA HUMANO.
CHLAMYDIA TRACHOMATIS VIRCLIA®IGA/IGG/IGM MONOTEST ES UNINMUNOENSAYO QUIMIOLUMINISCENTEINDIRECTO (CLIA) PARA DETERMINARANTICUERPOS IGA, IGG E IGM ESPECÍFICOSFRENTE A CHLAMYDIA TRACHOMATIS ENSUERO/PLASMA HUMANO.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- INMUNOENSAYO QUIMIOLUMINISCENTEINDIRECTO PARA DETERMINARANTICUERPOSIGA,IGGEIGMESPECÍFICOSFRE
- Trade Name (English)
- INDIRECT CHEMILUMINESCENT IMMUNOASSAY TO DETERMINEANTIBODIESSIGA, IGGEIGMSPECIFICFRE
- Analysis ID
- 1404R2021 SSA
- Registration Date
- September 13, 2021
- Name (Spanish)
- KABLACOMERCIAL,S.A.DE C.V.
- Name (English)
- KABLACOMERCIAL,S.A.DE C.V.
Access comprehensive regulatory information for CHLAMYDIA TRACHOMATISVIRCLIA® IGA/IGG/IGM MONOTEST (CHLAMYDIA TRACHOMATISVIRCLIA® IGA/IGG/IGM MONOTEST) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1404R2021 SSA and manufactured by KABLACOMERCIAL,S.A.DE C.V.. The device was registered on September 13, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.